

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of interleukin-8 secretion (GO:2000484) | 8.47975906 |
| 2 | negative regulation of B cell proliferation (GO:0030889) | 8.18088690 |
| 3 | regulation of regulatory T cell differentiation (GO:0045589) | 7.79542961 |
| 4 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 7.52551112 |
| 5 | intestinal epithelial cell development (GO:0060576) | 7.29916651 |
| 6 | positive regulation of B cell differentiation (GO:0045579) | 7.20837955 |
| 7 | pyrimidine nucleoside catabolic process (GO:0046135) | 6.10450763 |
| 8 | regulation of interleukin-8 secretion (GO:2000482) | 5.96967832 |
| 9 | eosinophil chemotaxis (GO:0048245) | 5.93957231 |
| 10 | negative regulation by host of viral transcription (GO:0043922) | 5.51862843 |
| 11 | negative regulation of B cell activation (GO:0050869) | 5.43599081 |
| 12 | eosinophil migration (GO:0072677) | 5.37553499 |
| 13 | regulation of B cell differentiation (GO:0045577) | 5.20563174 |
| 14 | maternal placenta development (GO:0001893) | 5.20360310 |
| 15 | positive T cell selection (GO:0043368) | 5.15944032 |
| 16 | positive thymic T cell selection (GO:0045059) | 5.09526719 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.99580354 |
| 18 | DNA demethylation (GO:0080111) | 4.84956293 |
| 19 | negative regulation of viral genome replication (GO:0045071) | 4.84538139 |
| 20 | positive regulation of lymphocyte migration (GO:2000403) | 4.76030555 |
| 21 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.47237432 |
| 22 | macrophage chemotaxis (GO:0048246) | 4.43362930 |
| 23 | regulation of activation of Janus kinase activity (GO:0010533) | 4.38566442 |
| 24 | regulation of chronic inflammatory response (GO:0002676) | 4.35329849 |
| 25 | actin nucleation (GO:0045010) | 4.29572275 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.10440731 |
| 27 | negative regulation of T cell apoptotic process (GO:0070233) | 4.05938312 |
| 28 | positive regulation of T cell migration (GO:2000406) | 3.99866549 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.94944889 |
| 30 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.93703372 |
| 31 | trophoblast giant cell differentiation (GO:0060707) | 3.85418138 |
| 32 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.82994166 |
| 33 | DNA dealkylation (GO:0035510) | 3.80868064 |
| 34 | regulation of T cell chemotaxis (GO:0010819) | 3.77467287 |
| 35 | positive regulation of T cell chemotaxis (GO:0010820) | 3.77467287 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 3.77054744 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.76987989 |
| 38 | positive regulation of tolerance induction (GO:0002645) | 3.71587141 |
| 39 | positive regulation of defense response to virus by host (GO:0002230) | 3.64852330 |
| 40 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.63156032 |
| 41 | T cell costimulation (GO:0031295) | 3.59164877 |
| 42 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.58298718 |
| 43 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.57646669 |
| 44 | diterpenoid biosynthetic process (GO:0016102) | 3.57511540 |
| 45 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.55644146 |
| 46 | lymphocyte costimulation (GO:0031294) | 3.54783628 |
| 47 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.52587573 |
| 48 | regulation of lymphocyte migration (GO:2000401) | 3.48224646 |
| 49 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.46479771 |
| 50 | regulation of T cell migration (GO:2000404) | 3.44734711 |
| 51 | regulation of mononuclear cell migration (GO:0071675) | 3.42299488 |
| 52 | positive regulation of chemokine secretion (GO:0090197) | 3.42139148 |
| 53 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.38740383 |
| 54 | dendritic cell chemotaxis (GO:0002407) | 3.37762529 |
| 55 | regulation of viral genome replication (GO:0045069) | 3.36012031 |
| 56 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.33977308 |
| 57 | T cell migration (GO:0072678) | 3.31906859 |
| 58 | thymic T cell selection (GO:0045061) | 3.29940480 |
| 59 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.24032604 |
| 60 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.23978964 |
| 61 | monocyte chemotaxis (GO:0002548) | 3.22985761 |
| 62 | negative regulation of viral transcription (GO:0032897) | 3.22210071 |
| 63 | cellular response to interleukin-15 (GO:0071350) | 3.17050590 |
| 64 | negative regulation of viral process (GO:0048525) | 3.15971985 |
| 65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13303829 |
| 66 | negative T cell selection (GO:0043383) | 3.12920752 |
| 67 | regulation of tolerance induction (GO:0002643) | 3.05857840 |
| 68 | regulation of macrophage chemotaxis (GO:0010758) | 3.02855652 |
| 69 | positive regulation of interleukin-8 production (GO:0032757) | 3.02466654 |
| 70 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.01182074 |
| 71 | negative regulation of macroautophagy (GO:0016242) | 2.99811021 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 2.98471696 |
| 73 | T cell selection (GO:0045058) | 2.97952489 |
| 74 | regulation of chemokine secretion (GO:0090196) | 2.96521369 |
| 75 | T cell receptor signaling pathway (GO:0050852) | 2.93243557 |
| 76 | chemokine-mediated signaling pathway (GO:0070098) | 2.89735468 |
| 77 | regulation of interleukin-1 secretion (GO:0050704) | 2.89073417 |
| 78 | negative regulation of response to biotic stimulus (GO:0002832) | 2.85781540 |
| 79 | cellular response to interferon-beta (GO:0035458) | 2.85726062 |
| 80 | negative regulation of lymphocyte proliferation (GO:0050672) | 2.85711752 |
| 81 | negative regulation of mononuclear cell proliferation (GO:0032945) | 2.85711752 |
| 82 | lymphocyte chemotaxis (GO:0048247) | 2.84401761 |
| 83 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.84209951 |
| 84 | locomotory exploration behavior (GO:0035641) | 2.83944700 |
| 85 | cytolysis (GO:0019835) | 2.83280779 |
| 86 | activated T cell proliferation (GO:0050798) | 2.82258767 |
| 87 | positive regulation of T cell apoptotic process (GO:0070234) | 2.80725917 |
| 88 | positive regulation of macrophage differentiation (GO:0045651) | 2.80502021 |
| 89 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.79867145 |
| 90 | negative regulation of lymphocyte differentiation (GO:0045620) | 2.76911095 |
| 91 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.76702140 |
| 92 | response to interferon-beta (GO:0035456) | 2.76105521 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73407205 |
| 94 | biotin metabolic process (GO:0006768) | 2.73029818 |
| 95 | cytidine deamination (GO:0009972) | 15.0417325 |
| 96 | cytidine metabolic process (GO:0046087) | 15.0417325 |
| 97 | cytidine catabolic process (GO:0006216) | 15.0417325 |
| 98 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 13.2639924 |
| 99 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 10.7493755 |
| 100 | DNA deamination (GO:0045006) | 10.3386908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.41825665 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.26653913 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.01316934 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.83287027 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.66565650 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.37437570 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.17119379 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.88383329 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.75206233 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.60006991 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.45912476 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.43363500 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.41175118 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.39350280 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21121138 |
| 16 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.02583407 |
| 17 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.02583407 |
| 18 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.02583407 |
| 19 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.01365974 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.8411515 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 1.95579914 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78991873 |
| 23 | GATA3_26560356_Chip-Seq_TH2_Human | 1.77668884 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76787285 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76747066 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65954194 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55771845 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54258214 |
| 29 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.47545883 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39524322 |
| 31 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38919181 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36285390 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35163502 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 1.32664794 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32368220 |
| 36 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.31076790 |
| 37 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.26910559 |
| 38 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.19736714 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18596929 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18298473 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16491144 |
| 42 | GATA3_26560356_Chip-Seq_TH1_Human | 1.16444745 |
| 43 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14998431 |
| 44 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.14895085 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13269100 |
| 46 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.10330081 |
| 47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10221470 |
| 48 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05086616 |
| 49 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04934169 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.03584168 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.03496904 |
| 52 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03479972 |
| 53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00951143 |
| 54 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00433654 |
| 55 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00433654 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00315697 |
| 57 | AR_20517297_ChIP-Seq_VCAP_Human | 0.99984799 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99649909 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99044011 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98182743 |
| 61 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96880697 |
| 62 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95534952 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93171625 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91912252 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91692672 |
| 66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90944326 |
| 67 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90435955 |
| 68 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89012319 |
| 69 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.88061955 |
| 70 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.85774897 |
| 71 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85634379 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84718949 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84194691 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82151325 |
| 75 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.82091103 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81919801 |
| 77 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.80218420 |
| 78 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79991678 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.78249607 |
| 80 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.77524021 |
| 81 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.77481429 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.76898631 |
| 83 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.76872893 |
| 84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.75849625 |
| 85 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75414332 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75413134 |
| 87 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.73284160 |
| 88 | NCOR_22424771_ChIP-Seq_293T_Human | 0.73261717 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72901329 |
| 90 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.72382699 |
| 91 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.71745380 |
| 92 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.71428206 |
| 93 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.71367636 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.70612969 |
| 95 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.70439977 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70073866 |
| 97 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.69822531 |
| 98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69145732 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 0.67558159 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.67493294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.51953756 |
| 2 | MP0001873_stomach_inflammation | 5.18857569 |
| 3 | MP0001853_heart_inflammation | 3.84909155 |
| 4 | MP0009333_abnormal_splenocyte_physiolog | 3.49763556 |
| 5 | MP0009785_altered_susceptibility_to | 3.47150238 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.00613177 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.81041094 |
| 8 | MP0001919_abnormal_reproductive_system | 2.65768826 |
| 9 | MP0000372_irregular_coat_pigmentation | 2.61241074 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.58713571 |
| 11 | MP0003011_delayed_dark_adaptation | 2.54274513 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.53563684 |
| 13 | MP0002163_abnormal_gland_morphology | 2.44796664 |
| 14 | MP0006082_CNS_inflammation | 2.36914533 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.32078521 |
| 16 | MP0005025_abnormal_response_to | 2.21555593 |
| 17 | MP0005310_abnormal_salivary_gland | 2.20744794 |
| 18 | MP0001800_abnormal_humoral_immune | 2.19583832 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.12004591 |
| 20 | MP0002933_joint_inflammation | 2.06424241 |
| 21 | MP0001188_hyperpigmentation | 2.04873137 |
| 22 | MP0001819_abnormal_immune_cell | 2.03139494 |
| 23 | MP0002723_abnormal_immune_serum | 2.01559399 |
| 24 | MP0003866_abnormal_defecation | 1.99534752 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.88200090 |
| 26 | MP0000716_abnormal_immune_system | 1.86375164 |
| 27 | MP0002405_respiratory_system_inflammati | 1.79006457 |
| 28 | MP0003448_altered_tumor_morphology | 1.76398466 |
| 29 | MP0000733_abnormal_muscle_development | 1.74541253 |
| 30 | MP0005389_reproductive_system_phenotype | 1.74104938 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.71494441 |
| 32 | MP0002398_abnormal_bone_marrow | 1.70611102 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.66248794 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.63612283 |
| 35 | MP0009379_abnormal_foot_pigmentation | 1.60423546 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.60101870 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.46981645 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.45771024 |
| 39 | MP0002722_abnormal_immune_system | 1.45595553 |
| 40 | MP0006054_spinal_hemorrhage | 1.44716077 |
| 41 | MP0001790_abnormal_immune_system | 1.41119209 |
| 42 | MP0005387_immune_system_phenotype | 1.41119209 |
| 43 | MP0010307_abnormal_tumor_latency | 1.39627406 |
| 44 | MP0002429_abnormal_blood_cell | 1.38903725 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.38729433 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.37797962 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.37306280 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.29373320 |
| 49 | MP0009765_abnormal_xenobiotic_induced | 1.25931000 |
| 50 | MP0004381_abnormal_hair_follicle | 1.17886667 |
| 51 | MP0002419_abnormal_innate_immunity | 1.14659494 |
| 52 | MP0003137_abnormal_impulse_conducting | 1.14488358 |
| 53 | MP0002102_abnormal_ear_morphology | 1.10030967 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.06888648 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.06763978 |
| 56 | MP0003567_abnormal_fetal_cardiomyocyte | 1.05505271 |
| 57 | MP0004947_skin_inflammation | 0.99443184 |
| 58 | MP0009763_increased_sensitivity_to | 0.97685863 |
| 59 | MP0000613_abnormal_salivary_gland | 0.96638500 |
| 60 | MP0003786_premature_aging | 0.94780396 |
| 61 | MP0002006_tumorigenesis | 0.94768121 |
| 62 | MP0001984_abnormal_olfaction | 0.93853643 |
| 63 | MP0005623_abnormal_meninges_morphology | 0.93440800 |
| 64 | MP0003045_fibrosis | 0.93138319 |
| 65 | MP0008789_abnormal_olfactory_epithelium | 0.92909296 |
| 66 | MP0008469_abnormal_protein_level | 0.90177000 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.87282624 |
| 68 | MP0001485_abnormal_pinna_reflex | 0.85918542 |
| 69 | MP0005410_abnormal_fertilization | 0.85422886 |
| 70 | MP0003878_abnormal_ear_physiology | 0.84650799 |
| 71 | MP0005377_hearing/vestibular/ear_phenot | 0.84650799 |
| 72 | MP0002234_abnormal_pharynx_morphology | 0.83369541 |
| 73 | MP0009764_decreased_sensitivity_to | 0.83240051 |
| 74 | MP0003436_decreased_susceptibility_to | 0.82680281 |
| 75 | MP0008873_increased_physiological_sensi | 0.82283060 |
| 76 | MP0004134_abnormal_chest_morphology | 0.76422734 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.74443541 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.73658571 |
| 79 | MP0002693_abnormal_pancreas_physiology | 0.73450542 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.69534493 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.68748507 |
| 82 | MP0000371_diluted_coat_color | 0.65732075 |
| 83 | MP0003075_altered_response_to | 0.65154683 |
| 84 | MP0004036_abnormal_muscle_relaxation | 0.62152835 |
| 85 | MP0008995_early_reproductive_senescence | 0.61932378 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.60852306 |
| 87 | MP0002396_abnormal_hematopoietic_system | 0.59349884 |
| 88 | MP0004145_abnormal_muscle_electrophysio | 0.59219114 |
| 89 | MP0003724_increased_susceptibility_to | 0.57601848 |
| 90 | MP0001663_abnormal_digestive_system | 0.56702738 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.55958218 |
| 92 | MP0000920_abnormal_myelination | 0.55556989 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.54334333 |
| 94 | MP0005408_hypopigmentation | 0.53950351 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.53379643 |
| 96 | MP0005499_abnormal_olfactory_system | 0.52698348 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.52698348 |
| 98 | MP0004130_abnormal_muscle_cell | 0.50849664 |
| 99 | MP0000685_abnormal_immune_system | 0.50285455 |
| 100 | MP0008007_abnormal_cellular_replicative | 0.47859234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ureteral stenosis (HP:0000071) | 6.10863280 |
| 2 | Abnormality of the prostate (HP:0008775) | 6.07289879 |
| 3 | Aplastic anemia (HP:0001915) | 5.73158382 |
| 4 | Ureteral obstruction (HP:0006000) | 5.69627730 |
| 5 | Abnormality of T cell number (HP:0011839) | 5.38580653 |
| 6 | Autoimmune hemolytic anemia (HP:0001890) | 5.36003629 |
| 7 | T lymphocytopenia (HP:0005403) | 5.20188524 |
| 8 | Pulmonary fibrosis (HP:0002206) | 4.70817736 |
| 9 | Chest pain (HP:0100749) | 4.65969127 |
| 10 | Gangrene (HP:0100758) | 4.51383827 |
| 11 | Hypoproteinemia (HP:0003075) | 4.47203467 |
| 12 | Pulmonary infiltrates (HP:0002113) | 4.46926358 |
| 13 | Obstructive lung disease (HP:0006536) | 4.21004417 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 4.21004417 |
| 15 | Oral leukoplakia (HP:0002745) | 4.03958497 |
| 16 | Hemoptysis (HP:0002105) | 4.00728056 |
| 17 | Abnormality of male internal genitalia (HP:0000022) | 3.99492686 |
| 18 | Pulmonary embolism (HP:0002204) | 3.69669121 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.63403277 |
| 20 | 3-Methylglutaconic aciduria (HP:0003535) | 3.57398010 |
| 21 | Abnormality of the pleura (HP:0002103) | 3.53697424 |
| 22 | Meningitis (HP:0001287) | 3.48732621 |
| 23 | Abnormality of the pericardium (HP:0001697) | 3.43660016 |
| 24 | Abnormality of T cells (HP:0002843) | 3.32037906 |
| 25 | Abnormal albumin level (HP:0012116) | 3.26816619 |
| 26 | Hypoalbuminemia (HP:0003073) | 3.26816619 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.26428071 |
| 28 | Seborrheic dermatitis (HP:0001051) | 3.25523493 |
| 29 | Carpal bone hypoplasia (HP:0001498) | 3.24392288 |
| 30 | Vasculitis (HP:0002633) | 3.23374285 |
| 31 | Severe visual impairment (HP:0001141) | 3.12386886 |
| 32 | Ketoacidosis (HP:0001993) | 3.03105105 |
| 33 | Chronic diarrhea (HP:0002028) | 2.99689101 |
| 34 | Thrombophlebitis (HP:0004418) | 2.94467019 |
| 35 | Restrictive lung disease (HP:0002091) | 2.82636143 |
| 36 | J-shaped sella turcica (HP:0002680) | 2.77415366 |
| 37 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.74673962 |
| 38 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.74673962 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.74616461 |
| 40 | Optic neuritis (HP:0100653) | 2.74616461 |
| 41 | Polyneuropathy (HP:0001271) | 2.73982159 |
| 42 | Glomerulopathy (HP:0100820) | 2.71816770 |
| 43 | Arterial thrombosis (HP:0004420) | 2.66506220 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.66331958 |
| 45 | Skin rash (HP:0000988) | 2.64742513 |
| 46 | Abnormality of the parietal bone (HP:0002696) | 2.56788291 |
| 47 | Increased intramyocellular lipid droplets (HP:0012240) | 2.56558236 |
| 48 | Periorbital edema (HP:0100539) | 2.56345601 |
| 49 | Facial edema (HP:0000282) | 2.56043846 |
| 50 | Recurrent skin infections (HP:0001581) | 2.55144092 |
| 51 | Tachypnea (HP:0002789) | 2.51195046 |
| 52 | IgG deficiency (HP:0004315) | 2.47934435 |
| 53 | Alveolar cell carcinoma (HP:0006519) | 2.43757514 |
| 54 | Epistaxis (HP:0000421) | 2.42000505 |
| 55 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.41850517 |
| 56 | Hematochezia (HP:0002573) | 2.38306147 |
| 57 | Amaurosis fugax (HP:0100576) | 2.37699499 |
| 58 | Progressive external ophthalmoplegia (HP:0000590) | 2.34877720 |
| 59 | Recurrent bronchitis (HP:0002837) | 2.34421436 |
| 60 | Retinopathy (HP:0000488) | 2.31178922 |
| 61 | Premature graying of hair (HP:0002216) | 2.31112229 |
| 62 | Increased muscle lipid content (HP:0009058) | 2.29972781 |
| 63 | Paresthesia (HP:0003401) | 2.29374544 |
| 64 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.27584021 |
| 65 | Pancreatitis (HP:0001733) | 2.26701955 |
| 66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26691162 |
| 67 | Joint swelling (HP:0001386) | 2.26330106 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.22844184 |
| 69 | Diplopia (HP:0000651) | 2.22844184 |
| 70 | Acute necrotizing encephalopathy (HP:0006965) | 2.22611895 |
| 71 | Orchitis (HP:0100796) | 2.22310499 |
| 72 | Abnormal tarsal ossification (HP:0008369) | 2.21382715 |
| 73 | Abnormality of macrophages (HP:0004311) | 2.21256917 |
| 74 | Increased IgM level (HP:0003496) | 2.17982961 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.14151325 |
| 76 | Abnormality of eosinophils (HP:0001879) | 2.13226792 |
| 77 | Lymphopenia (HP:0001888) | 2.12404412 |
| 78 | Dysautonomia (HP:0002459) | 2.08918472 |
| 79 | Absent hand (HP:0004050) | 2.06015948 |
| 80 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.03186995 |
| 81 | Myositis (HP:0100614) | 1.99424455 |
| 82 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.97787688 |
| 83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96682360 |
| 84 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96682360 |
| 85 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96682360 |
| 86 | Recurrent otitis media (HP:0000403) | 1.95144078 |
| 87 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.93161180 |
| 88 | Pigmentary retinal degeneration (HP:0001146) | 1.92808835 |
| 89 | Eosinophilia (HP:0001880) | 1.91302962 |
| 90 | Thyroiditis (HP:0100646) | 1.90977357 |
| 91 | Amyotrophic lateral sclerosis (HP:0007354) | 1.90668791 |
| 92 | Progressive macrocephaly (HP:0004481) | 1.82593418 |
| 93 | Mitochondrial inheritance (HP:0001427) | 1.81889143 |
| 94 | Hypoplasia of the thymus (HP:0000778) | 1.80267306 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 1.80162307 |
| 96 | Mediastinal lymphadenopathy (HP:0100721) | 1.80113700 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 1.73513836 |
| 98 | Hemiplegia (HP:0002301) | 1.72936779 |
| 99 | Anhidrosis (HP:0000970) | 1.72283608 |
| 100 | Flat capital femoral epiphysis (HP:0003370) | 1.71658005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 3.81004716 |
| 2 | MST4 | 3.31191884 |
| 3 | BMPR1B | 3.07865588 |
| 4 | FES | 2.13070469 |
| 5 | ITK | 2.03575213 |
| 6 | TXK | 12.8567774 |
| 7 | MAP2K6 | 1.83119260 |
| 8 | MAP4K1 | 1.82321703 |
| 9 | RIPK4 | 1.82105814 |
| 10 | NTRK1 | 1.79750190 |
| 11 | PIK3CG | 1.71254296 |
| 12 | SCYL2 | 1.65674552 |
| 13 | CSK | 1.58042045 |
| 14 | MATK | 1.55640511 |
| 15 | TYRO3 | 1.52914140 |
| 16 | GRK7 | 1.42068655 |
| 17 | MAP3K13 | 1.35642381 |
| 18 | ADRBK2 | 1.31811484 |
| 19 | TRIM28 | 1.24508936 |
| 20 | IKBKB | 1.23444992 |
| 21 | LCK | 1.18025728 |
| 22 | SYK | 1.13311648 |
| 23 | PRKCQ | 1.10192472 |
| 24 | WNK4 | 1.00575279 |
| 25 | EIF2AK3 | 0.99796232 |
| 26 | BMPR2 | 0.94583330 |
| 27 | JAK2 | 0.87017924 |
| 28 | GRK1 | 0.86864874 |
| 29 | OXSR1 | 0.83719861 |
| 30 | FYN | 0.83467361 |
| 31 | BUB1 | 0.80893258 |
| 32 | TAOK3 | 0.80847582 |
| 33 | PIM2 | 0.79470584 |
| 34 | TIE1 | 0.72621379 |
| 35 | CSF1R | 0.72406535 |
| 36 | IGF1R | 0.71475446 |
| 37 | ZAK | 0.70904434 |
| 38 | STK39 | 0.65093624 |
| 39 | LYN | 0.63573157 |
| 40 | TESK2 | 0.62083793 |
| 41 | FRK | 0.62055222 |
| 42 | MAP2K7 | 0.61976027 |
| 43 | ZAP70 | 0.61147276 |
| 44 | CAMKK2 | 0.57450214 |
| 45 | MYLK | 0.53421803 |
| 46 | JAK3 | 0.51380485 |
| 47 | TBK1 | 0.47456058 |
| 48 | BTK | 0.46675725 |
| 49 | OBSCN | 0.44692780 |
| 50 | IKBKE | 0.43169305 |
| 51 | PINK1 | 0.42639397 |
| 52 | INSRR | 0.42200293 |
| 53 | CHUK | 0.41173469 |
| 54 | INSR | 0.40564676 |
| 55 | PDGFRB | 0.39337645 |
| 56 | CAMK2A | 0.38562030 |
| 57 | ARAF | 0.36410093 |
| 58 | NEK6 | 0.35906356 |
| 59 | BLK | 0.34836142 |
| 60 | ERBB2 | 0.34547923 |
| 61 | TEC | 0.32257767 |
| 62 | MUSK | 0.31773054 |
| 63 | ROCK1 | 0.31293414 |
| 64 | MAP3K9 | 0.31132575 |
| 65 | PDK1 | 0.30726279 |
| 66 | SRPK1 | 0.30712248 |
| 67 | PIK3CA | 0.29522679 |
| 68 | TGFBR2 | 0.28609419 |
| 69 | IRAK4 | 0.28344356 |
| 70 | PRKCA | 0.27068142 |
| 71 | GRK5 | 0.26314081 |
| 72 | EGFR | 0.26284810 |
| 73 | PIM1 | 0.25868556 |
| 74 | PRKACA | 0.24586942 |
| 75 | GRK6 | 0.23718721 |
| 76 | CAMK2D | 0.22991097 |
| 77 | VRK2 | 0.22939057 |
| 78 | STK11 | 0.22003162 |
| 79 | MAP4K2 | 0.20822588 |
| 80 | BCR | 0.20292557 |
| 81 | MAPKAPK5 | 0.17662299 |
| 82 | TNK2 | 0.17304917 |
| 83 | ATR | 0.16507914 |
| 84 | PAK1 | 0.16379402 |
| 85 | PRKCG | 0.16078391 |
| 86 | DAPK3 | 0.16026370 |
| 87 | MAPK3 | 0.15935499 |
| 88 | AURKA | 0.15668769 |
| 89 | DYRK1A | 0.15408305 |
| 90 | NUAK1 | 0.15204770 |
| 91 | ABL1 | 0.14699519 |
| 92 | PAK3 | 0.14685556 |
| 93 | FGR | 0.13949119 |
| 94 | MAPKAPK2 | 0.13710100 |
| 95 | CAMK2G | 0.13371772 |
| 96 | PRKCD | 0.12988904 |
| 97 | MAPK9 | 0.12628940 |
| 98 | PRKACB | 0.12209415 |
| 99 | MOS | 0.12101054 |
| 100 | NEK1 | 0.11830852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.02318431 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.85701993 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.30947041 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 4.20796857 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.64483654 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.42769839 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.10833031 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.08985390 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.92776039 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.80481770 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.55701890 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.49659809 |
| 13 | Salmonella infection_Homo sapiens_hsa05132 | 2.21799402 |
| 14 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.88085757 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.83606639 |
| 16 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.79070215 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62428142 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58619426 |
| 19 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.57164517 |
| 20 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.54017005 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53976183 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.49852427 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.41642252 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30987447 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.21008500 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.20977957 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.20016708 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.17283385 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.14761945 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.14559716 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12720252 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07533625 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03921472 |
| 34 | Asthma_Homo sapiens_hsa05310 | 0.98178685 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95475293 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85142668 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 0.78015455 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74338090 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70005087 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66852406 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64926446 |
| 42 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64859330 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64620543 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63631000 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63473283 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62907107 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62513474 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61186389 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59654361 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59198933 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.57764473 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 0.56714573 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52414848 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.52171316 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48147742 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47999863 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.47610355 |
| 58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46236740 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45474219 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.45079846 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44211476 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42861941 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41760962 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41221686 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39733675 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38716337 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37394552 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36604747 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36589706 |
| 70 | Homologous recombination_Homo sapiens_hsa03440 | 0.33045741 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.32939682 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31773440 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31485006 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31019270 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30292378 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.28551168 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.27789982 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.27276659 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.24121946 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.23498644 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21420063 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17598321 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16333729 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15874709 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.10940166 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.10031808 |
| 87 | Ribosome_Homo sapiens_hsa03010 | 0.09219263 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.08252831 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.06956980 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.06486034 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.04984299 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.04324235 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.03922705 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.03731786 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03303449 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.03102303 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.01109958 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.00790827 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | -0.0030254 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0005911 |

